Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Testing TMS with language therapy for word-finding after stroke

Tests magnetic brain stimulation with word therapy in adults with stroke-related aphasia.

Plain-language title generated from the registry record
Registry title: Post-Stroke Aphasia TMS

Key facts

Where
Milwaukee, United StatesSee the site

Where in United States

  • Medical College of WisconsinMilwaukee, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical College of Wisconsin
Trial code
NCT06974279
Record updated
10 July 2026
Original description
The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).Read full original descriptionShow less

Precision Neuromodulation in Post-Stroke Aphasia Using TMS

The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).

Inclusion: Diagnosed with left hemisphere stroke; Consent date >= 1 month after stroke onset; Fluent in English; 18 years of age or older.

Exclusion: Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease); A chronic medical condition that is not treated or is unstable; The presence of cardiac stimulators or pacemakers or intracardiac lines, neurostimulators, medication infusion device, any other implants near the scalp (e.g., cochlear implants) or in the eye, metal in the body (e.g., splinters, fragments, clips); History of skull fractures, or skin diseases; History of ongoing or unmanaged seizures; Presence of factors that potentially decrease seizure thresholds: on pro-convulsant medications, untreated sleep deprivation or insomnia, ongoing alcoholism or illegal drug abuse (e.g., cocaine or MDMA users); History of dyslexia or other developmental learning disabilities; Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing; Pregnancy.

ClinicalTrials.gov NCT06974279